ConductScience.org, home

Paper16622227

Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.

Pinder M and 8 others. Infect Immun, 2006. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children. Papers, record 16622227. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16622227

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.
PubMed
Journal
Infect Immun
PubMed
Year
2006
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.34
iCite
Revised in PubMed
2025-05-29
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pinder MMargaret
2Sutherland CJColin J
3Sisay-Joof FFatoumatta
4Ismaili JJamila
5McCall MBMatthew B B
6Ord RRosalyn
7Hallett RRachel
8Holder AAAnthony A
9Milligan PPaul

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, ProtozoanMajor topic
Antigens, ProtozoanMajor topic
AntimalarialsMajor topic
ChloroquineMajor topic
Immunoglobulin GMajor topic
Malaria, FalciparumMajor topic
Membrane ProteinsMajor topic
Merozoite Surface Protein 1Major topic
Plasmodium falciparumMajor topic
Protozoan ProteinsMajor topic
Animals
Child
Child, Preschool
Humans
Infant
Malaria Vaccines
Parasitemia
Retrospective Studies

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Wellcome TrustUnited KingdomPubMed
MC_U117532067Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19647243A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan.J Immunol1998https://conductscience.org/library/papers/9647243PubMed
212183594The human immune response to Plasmodium falciparum includes both antibodies that inhibit merozoite surface protein 1 secondary processing and blocking antibodies.Infect Immun2002https://conductscience.org/library/papers/12183594PubMed
311160024Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum.Infect Immun2001https://conductscience.org/library/papers/11160024PubMed
411567708Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria.Lancet2001https://conductscience.org/library/papers/11567708PubMed
510497996Immune responses against Plasmodium falciparum asexual blood-stage antigens and disease susceptibility in Gabonese and Cameroonian children.Am J Trop Med Hyg1999https://conductscience.org/library/papers/10497996PubMed
614695097Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria.Am J Trop Med Hyg2003https://conductscience.org/library/papers/14695097PubMed
711172152A molecular marker for chloroquine-resistant falciparum malaria.N Engl J Med2001https://conductscience.org/library/papers/11172152PubMed
83523398
Protective immunity to malaria. Studies with cloned lines of Plasmodium chabaudi chabaudi and P. berghei in CBA/Ca mice. II. The effectiveness and inter- or intra-species specificity of the passive transfer of immunity with serum.
Parasite Immunol1986https://conductscience.org/library/papers/3523398PubMed
916206082Carriage of chloroquine-resistant parasites and delay of effective treatment increase the risk of severe malaria in Gambian children.J Infect Dis2005https://conductscience.org/library/papers/16206082PubMed
109502606
A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia.
Am J Trop Med Hyg1998https://conductscience.org/library/papers/9502606PubMed
1115542195Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria.Vaccine2004https://conductscience.org/library/papers/15542195PubMed
121694225A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.J Exp Med1990https://conductscience.org/library/papers/1694225PubMed
1313880318Gamma-globulin and acquired immunity to human malaria.Nature1961https://conductscience.org/library/papers/13880318PubMed
1411292349Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum.J Mol Biol2001https://conductscience.org/library/papers/11292349PubMed
1512117958High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion.Infect Immun2002https://conductscience.org/library/papers/12117958PubMed
1610697894Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria.Parassitologia1999https://conductscience.org/library/papers/10697894PubMed
1712518847Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes.Am J Trop Med Hyg2002https://conductscience.org/library/papers/12518847PubMed
188627050Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.J Infect Dis1996https://conductscience.org/library/papers/8627050PubMed
193299709Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.Science1987https://conductscience.org/library/papers/3299709PubMed
2015388456Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/15388456PubMed

See all 37 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
33763871Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations.Clin Pharmacol Ther2021https://conductscience.org/library/papers/33763871PubMed
28427418Immunity as a predictor of anti-malarial treatment failure: a systematic review.Malar J2017https://conductscience.org/library/papers/28427418PubMed
28289193Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28289193PubMed
23285095Associations between antibodies to a panel of Plasmodium falciparum specific antigens and response to sub-optimal antimalarial therapy in Kampala, Uganda.PLoS One2012https://conductscience.org/library/papers/23285095PubMed
19500037Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy.J Infect Dis2009https://conductscience.org/library/papers/19500037PubMed
19250541AFCo1, a meningococcal B-derived cochleate adjuvant, strongly enhances antibody and T-cell immunity against Plasmodium falciparum merozoite surface protein 4 and 5.Malar J2009https://conductscience.org/library/papers/19250541PubMed
18495848Impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on antibody responses to erythrocytic-stage Plasmodium falciparum antigens in infants in Mozambique.Clin Vaccine Immunol2008https://conductscience.org/library/papers/18495848PubMed
18053225How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions?Malar J2007https://conductscience.org/library/papers/18053225PubMed
18021388Potential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum.Malar J2007https://conductscience.org/library/papers/18021388PubMed
17223628Molecular epidemiology of malaria.Clin Microbiol Rev2007https://conductscience.org/library/papers/17223628PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16622227

GET https://conductscience.org/api/papers/v1/16622227/references?page=2